ICICI Securities
-
Metropolis Share Price Gains On ICICI Securities 'Buy' Call— Check Target Price
The brokerage believes the recent and future M&A could, provide a meaningful upside to Metropolis' growth, particularly in expanding reach in existing geographies, enhancement of new technology and test menu and potential foray into unexplored regions across India.
-
Oil India Share Price Target Raised by ICICI Securities; Stock Remains Top Pick — Here's Why
Oil India continues to build momentum across both core upstream as well as downstream segments, adds the brokerage.
-
Voltas' AC Business Gains Market Share After Q1; ICICI Securities Maintains Add — Check Target Price
Voltas delivered a strong Q1 performance, led by robust RAC demand with further strengthening its market leadership, highlights the brokerage.
-
10 Stocks In Focus After Q1 Results: ICICI Securities Hikes Targets On VA Tech Wabag, Solar Industries, Indigo Paints And More — Details Inside
Based on the brokerage's cited market prices, IndiQube offers the highest potential upside at 42%, followed by VA Tech Wabag at 28%.
-
Mamaearth Parent Honasa Shares May Rally 50%, Says ICICI Securities After Strong Q1 Results — Check Hiked Target Price
ICICI Securities believes the stronger growth trajectory and improving profitability justify Honasa's higher earnings estimates and valuation.
-
Akums Drugs, CDSL, Ceigall India, Power Mech In Focus After Q1; ICICI Securities Sees Up To 22% Upside — Check Ratings
Akums Drugs, CDSL, Ceigall and Power Mech have received fresh brokerage commentary from ICICI Securities following their June-quarter earnings, with the brokerage taking sharply different views across the four stocks.
-
Zee Entertainment Q1 Earnings Miss Triggers Rating Downgrade, Target Price Cut By ICICI Securities
The brokerage flagged persistent weakness in advertising revenue and an earnings miss as key concerns, even as subscription revenue remained strong and ZEE5 delivered another profitable quarter.
-
Titan To Hindalco Q1 Review: Buy, Add Or Hold? Here's ICICI Securities' Take
Titan Company, Fortis Healthcare, Hindalco Industries, Blue Star and Ramco Cements are in focus following their Q1 FY27 earnings, with ICICI Securities taking a differentiated view across the five stocks.
-
Cera, GE Vernova and Power Grid Shares In Focus After Q1 Results — Check Motilal Oswal's Latest Ratings, Target Prices, Upside
Cera, GE Vernova T&D India, Power Grid, Power Finance are among the stocks in focus after Motilal Oswal reviewed their June-quarter performance, with the brokerage highlighting strong execution, healthy order visibility and long-term growth opportunities across building materials and power infrastructure.
-
Hitachi Energy Gets Double Boost After Q1; ICICI Securities Upgrades Rating, Target Price — Here's Why
Revenue surged 69% YoY, profit more than doubled and order inflows exceeded expectations, prompting ICICI Securities to upgrade the stock to 'Buy'
-
Delhivery's Risk-Reward Remains Attractive Despite Q1 Margin Hit, Says ICICI Securities — Check Upside
The report highlighted that Delhivery continues to gain market share across key segments while benefiting from increasing outsourcing by e-commerce companies and new customer acquisitions.
-
Cohance Lifesciences' 'Weakest Quarter' Prompts Target Price Cut By ICICI Securities
Cohance's lower utilisation at manufacturing plants, higher overheads and continued losses at NJ bio resulted in exceptionally weak margin, adds the brokerage.
-
Defence Stocks To Buy: HAL, Solar Industries Among ICICI Securities' Top Bets As Order Cycle Picks Up — Check Full List
Given that DAC approvals of Rs 52,000 crore, were at an all-time high in FY26, the brokerage expects the order awarding momentum to pick up in FY27/28, especially in aerospace, missiles, electronic warfare and drone defence-offence side.
-
DOMS, United Breweries, Inox India, Orkla India: Here's What ICICI Securities Says After Q1 Results
DOMS Industries, Inox India and United Breweries, Orkla India are likely to remain in focus after ICICI Securities reviewed their June-quarter earnings, maintaining a constructive stance on all four stocks.
-
Alembic Pharma, KIMS Get Target Price Hikes After Q1, Latent View Sees Downgrade: ICICI Securities
Among the three, Alembic Pharma delivered one of the strongest performances.
